Neogenomics (NEO) Goodwill (2014 - 2026)

Neogenomics has reported Goodwill for 13 years, with the latest figure at $524.0 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill changed 0.24% year-over-year to $524.0 million; the trailing twelve-month figure through Mar 2026 stood at $524.0 million (changed 0.24% YoY), and the FY2025 full-year result was $524.3 million, changed 0.3% from the prior year.
• Goodwill for Q1 2026 stood at $524.0 million, roughly flat from $524.3 million in the prior quarter.
• The five-year high for Goodwill was $527.1 million in Q1 2022, with the low at $522.8 million in Q3 2022.
• Historically, Goodwill has averaged $523.6 million across 5 years, with a median of $522.8 million in 2022.
• The largest YoY upside for Goodwill was 149.7% in 2022 against a maximum downside of 0.83% in 2022.
• Neogenomics' Goodwill stood at $522.8 million in 2022, then changed by 0.0% to $522.8 million in 2023, then changed by 0.0% to $522.8 million in 2024, then advanced by 0.3% to $524.3 million in 2025, then declined by 0.07% to $524.0 million in 2026.
• The last three Goodwill figures came in at $524.0 million (Q1 2026), $524.3 million (Q4 2025), and $524.3 million (Q3 2025), per Business Quant data.